NCT06716671View on ClinicalTrials.gov

Influence of Continuous Glucose Monitoring on Quality of Life in People With Type 2 Diabetes Mellitus

Active, not recruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Continuous Glucose MonitoringQuality of LifeType 2 Diabetes Mellitus (T2DM)
Trial Locations (1)

08007

IDIAP Jordi Gol, Barcelona

All Listed Sponsors
lead

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

NCT06716671 - Influence of Continuous Glucose Monitoring on Quality of Life in People With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter